GoodRx vs Mochi Health
GoodRx and Mochi Health sell different medications; this is what separates them.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Mochi Health
Best for: coaching bundled into the price rather than sold separately
Visit Mochi Health →If you are choosing between GoodRx and Mochi Health, price alone will not settle it. GoodRx leads our six-part score, 6.9 to 6.6.
GoodRx vs Mochi Health price
GoodRx publishes $149 a month. Mochi Health does not post a GLP-1 price we can quote, so you would only learn its cost after an intake.
Medications and formats
GoodRx lists tirzepatide and orforglipron; Mochi Health does not name its drug.
On format, GoodRx prices brand-name pens, while Mochi Health posts no priced format.
If you want the FDA-approved brand rather than a compounded version, GoodRx is the only one of the two with a brand-name price.
Where each one treats patients
GoodRx lists 50 states, and Mochi Health lists 15 states.
They overlap in 15 states. GoodRx alone covers 35 states, including Alaska, Alabama, Arkansas and California.
Pricing
GoodRx
Mochi Health
Membership is $79/mo plus $60/mo for compounded semaglutide. The $39 membership Mochi leads with is a first-month rate for new customers; the standard rate is $79 per month after that. The $60 is a 'starting at' price that varies by dose, the lowest rung rather than a flat rate. $99 is shown struck through beside it.
Membership is $79/mo plus $90/mo for compounded tirzepatide. The $39 membership is a first-month promotional rate; the standard rate is $79. The $90 is a 'starting at' price that varies by dose. $199 is shown struck through beside it.
What each price covers
Mochi Health's price also covers the clinician visit and coaching, which GoodRx does not claim.
GoodRx does not say what its price includes.
Mochi Health is silent on shipping and lab work.
GoodRx
Inclusions not disclosed.
Mochi Health
Covered by the monthly price
Medication
Charged on top
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
In the price
Where each one scores higher
Overall, GoodRx scores 6.9 and Mochi Health 6.6 out of 10.
GoodRx is stronger on value (5.0 vs 3.0), accessibility (10.0 vs 4.4) and support (5.0 vs 4.0).
Mochi Health is stronger on user experience (8.0 vs 5.0) and trust & safety (8.5 vs 6.0).
Effectiveness is within half a point.
GoodRx
6.9/10
Mochi Health
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither GoodRx nor Mochi Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | GoodRx | Mochi Health |
|---|---|---|
| Starting Price | $149/mo | Not published |
| Features | ✓6 features | 3 features |
| States Available | ✓50 | 15 |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About GoodRx
GoodRx (NASDAQ: GDRX) is the largest US prescription savings platform. It publishes self-pay discount pricing on brand-name GLP-1 medications, with Foundayo (orforglipron) starting at $149/month and the Zepbound KwikPen (tirzepatide) starting at $299/month, redeemable at 70,000+ pharmacies nationwide. It also operates GoodRx Care, a telehealth arm that prescribes GLP-1s with online visits starting at $39.
Read our full GoodRx review →About Mochi Health
Mochi Health is an obesity medicine telehealth seller running aggressively priced compounded GLP-1 programs.
Read our full Mochi Health review →Pros & Cons
GoodRx
What we like
- Orforglipron costs $149 a month, close to the $149 median for brand-name orforglipron across the sellers we compare
- Tirzepatide costs $299 a month, 76% below the $1249 median for brand-name tirzepatide across the sellers we compare
- Serves all 50 states
- We found no FDA warning letters issued to GoodRx
Watch-outs
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Mochi Health
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes clinician visits and coaching
- We found no FDA warning letters issued to Mochi Health
Watch-outs
- Not included in the monthly price: medication
- Serves only 15 states, so check that yours is one of them
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
GoodRx wins this one, 6.9 to 6.6, above all for oral orforglipron alongside the injectables. Mochi Health fits better if coaching bundled into the price rather than sold separately is your priority.
Choose GoodRx if…
You want oral orforglipron alongside the injectables and an opening price near $149 a month.
Choose Mochi Health if…
You want coaching bundled into the price rather than sold separately.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →GoodRx vs Mochi Health: FAQ
Close alternatives to GoodRx and Mochi Health
- GoodRx vs Found
- GoodRx vs Kin Meds
- GoodRx vs PrideRx
- GoodRx vs PreventiveMD
- Mochi Health vs Embody
- Mochi Health vs TrimRx
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.